To ask the Scottish Government, in light of the projection set out in the Public Health Scotland report, Future prevalence and burden of chronic liver disease, which was published on 18 March 2025, that chronic liver disease cases will increase by 54% by 2044 due to alcohol misuse, what action it plans to take to address this issue.
Scottish Government notes this report with interest and is fully aware that the risk of liver disease is increased by the impact of harmful alcohol use and obesity.
This is why we are determined to do all we can to reduce alcohol-related harm, one of the most pressing public health challenges that we face in Scotland. We take a whole population approach to tackling such harm, in line with the World Health Organisation’s focus on affordability, availability and attractiveness of alcohol.
Our Alcohol Framework 2018 contains 20 actions to tackle alcohol-related harm. One of the key actions was the implementation of Minimum Unit Pricing (MUP) in May 2018. Since then, we have seen a reduction of 3% in total alcohol sales,with a focus on the cheap high-strength alcohol which is often drunk by people drinking at harmful levels. Recent research by Public Health Scotland has found that MUP has been found to save more than 150 lives a year and 411 fewer hospital admissions. It’s also encouraging to see that this research has highlighted that the policy is having an effect in Scotland’s most deprived areas – which experience higher death rates and levels of harms from problem alcohol.
We also want everyone in Scotland to eat well and have a healthy weight to help reduce the impact of a range of diet-related ill health conditions, including liver disease. We continue to implement the wide-ranging actions set out in our 2018 Diet and Healthy Weight Delivery Plan to address this challenge. This includes our commitment to restrict less healthy food promotions and improve the availability of healthier options when eating out, as outlined in our Out Of Home Action Plan.
Scottish Government through its national Centre for Sustainable Delivery (CfSD) has formed a Specialty Delivery Group for Liver Disease with the first meeting on 6th November 2024. Early Detection is one of the pathways being prioritised.
The Early Detection Pathway has already been passed through the first Gateway in the CfSD delivery pathway. The challenges are around how individual boards can implement this before the National Laboratory Information Management System.
There has been progress in developing the Early Detection pathways in individual health boards using the technology as currently available while others are using the Referral Advice to Primary Care with increased use of the FIB-4 and Fibroscan with advice for Lifestyle changes and repeat investigation as required.
